Essex Bio-Technology Investor Relations Material
Latest events
H2 2024
26 Mar, 2025
H1 2024
25 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Essex Bio-Technology Limited
Access all reports
Essex Bio-Technology Limited is a biopharmaceutical company engaged in the research, development, manufacturing, and marketing of therapeutic products. The company focuses on regenerative medicine and specializes in biopharmaceutical drugs for ophthalmology and wound care. Its product portfolio includes formulations derived from recombinant DNA technology and other biological sources. Essex Bio-Technology Limited conducts its operations through integrated facilities that support clinical research, production, and distribution. The company is headquartered in Hong Kong, China, and its shares are listed on the HKEX.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
1061
Country
🇭🇰 Hong Kong